NCT02793557View on ClinicalTrials.gov

Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
HypertrichosisAlopeciaHirsutism
Interventions
DRUG

FOL-005

Intradermal injection of 50 μl solution

OTHER

Placebo

Trial Locations (1)

10117

Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin, Berlin

Sponsors

Lead Sponsor

Follicum AB
All Listed Sponsors
lead

Follicum AB

INDUSTRY

NCT02793557 - Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth | Biotech Hunter | Biotech Hunter